Cargando…
Quercetin reverses the doxorubicin resistance of prostate cancer cells by downregulating the expression of c-met
Chemotherapy is an irreplaceable treatment for prostate cancer. However, the acquisition of chemoresistance is a common and critical problem that requires urgent solutions for the effective treatment of this disease. The aim of the present study was to determine whether the combination of quercetin...
Autores principales: | Shu, Yan, Xie, Bo, Liang, Zhen, Chen, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777119/ https://www.ncbi.nlm.nih.gov/pubmed/29434932 http://dx.doi.org/10.3892/ol.2017.7561 |
Ejemplares similares
-
Quercetin-induced cardioprotection against doxorubicin cytotoxicity
por: Chen, Jing-Yi, et al.
Publicado: (2013) -
MiR-204 enhances mitochondrial apoptosis in doxorubicin-treated prostate cancer cells by targeting SIRT1/p53 pathway
por: Shu, Yan, et al.
Publicado: (2017) -
Co-delivery of Cyclopamine and Doxorubicin Mediated by Bovine Serum Albumin Nanoparticles Reverses Doxorubicin Resistance in Breast Cancer by Down-regulating P-glycoprotein Expression
por: Lu, Yong-lin, et al.
Publicado: (2019) -
MDR1 Inhibition Reverses Doxorubicin-Resistance in Six Doxorubicin-Resistant Canine Prostate and Bladder Cancer Cell Lines
por: Packeiser, Eva-Maria, et al.
Publicado: (2023) -
Quercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion
por: Cao, Hui-Hui, et al.
Publicado: (2015)